• Wed. May 8th, 2024

The Newswire

  • Home
  • Blackhawk’s Mindbio Therapeutics Announces Research Collaborators at University of Auckland Receive Grant Funding of $1.44 Million for LSD Microdosing Trials in Major Depressive Disorder

Blackhawk’s Mindbio Therapeutics Announces Research Collaborators at University of Auckland Receive Grant Funding of $1.44 Million for LSD Microdosing Trials in Major Depressive Disorder

[ad_1] Successful grant comes after recent successful completion of Phase 1 LSD Microdosing LSD Trial in 80 participants  MindBio working exclusively in psychedelic microdosing clinical trials with University of Auckland…